期刊文献+

前列解毒胶囊联合盐酸坦洛新缓释片治疗慢性前列腺炎/慢性骨盆疼痛综合征的临床研究 被引量:2

Clinical study on treatment of chronic prostatitis/chronic pelvic pain syndrome
下载PDF
导出
摘要 目的探讨前列解毒胶囊联合盐酸坦洛新缓释片治疗慢性前列腺炎/慢性骨盆疼痛综合征的临床效果。方法选取我院2016年1月—2017年1月收治的慢性前列腺炎/慢性骨盆疼痛综合征患者100例,采取抽签法将其分为对照组和观察组,每组50例。对照组采用前列解毒胶囊联合左氧氟沙星进行治疗,观察组在此基础上加用盐酸坦洛新治疗,对2组患者的疼痛症状、慢性前列腺炎症状指数(NIH-CPSI)、白细胞(WBC)、生活质量等临床指标及不良反应发生率进行比较。结果观察组患者经过治疗后疼痛症状评分、WBC、NIH-CPSI评分均明显低于对照组(P<0.05);观察组生活质量评分明显优于对照组(P<0.05);2组患者不良反应发生率对比差异无统计学意义(P>0.05)。结论前列解毒胶囊联合盐酸坦洛新缓释片治疗慢性前列腺炎/慢性骨盆疼痛综合征临床疗效优异。 Objective To investigate the clinical effect of the forefront detoxification capsules combined withtylosine hydrochloride sustained-release tablets in the treatment of chronic prostatitis / chronic pelvic pain syndrome.Methods 100 cases of chronic prostatitis / chronic pelvic pain syndrome were enrolled in our hospital from June 20 toJune 2017,and 50 cases were divided into control group and observation group by lottery method. The control group wastreated with the first detoxification capsules combined with levofloxacin. The observation group was treated with the firstdetoxification capsules combined with levofloxacin hydrochloride and levofloxacin hydrochloride. The pain symptoms,NIH-CPSI (chronic prostatitis symptom index),WBC (white blood cell),Quality of life and other clinical indicatorsand the incidence of adverse reactions were scored and compared. Results The scores of WBC and NIH-CPSI weresignificantly lower in the observation group than those in the control group (P〈0.05) . The quality of life of the patientsafter treatment was significantly better than that of the control group(P〈0.05). There was no significant difference in theincidence of adverse reactions between the two groups (P〉0.05) . Conclusion The forefront of detoxification capsulescombined with tamsulosin hydrochloride sustained-release tablets in the treatment of chronic prostatitis / chronic pelvicpain syndrome clinical efficacy is excellent.
作者 甘建国 周女英 孙美蓉 Gan Jianguo;Zhou Nvying;Sun Meirong(The People 's Hospital of Fengcheng City, Fengcheng, Jiangxi 331100)
机构地区 丰城市人民医院
出处 《基层医学论坛》 2017年第31期4284-4285,共2页 The Medical Forum
基金 宜春市科技计划项目(JXYC2017KSB019)
关键词 慢性前列腺炎/慢性骨盆疼痛综合征 前列解毒胶囊 盐酸坦洛新缓释片 临床疗效 Chronic prostatitis/chronic pelvic pain syndrome Forefront of detoxification capsules Tylosinehydrochloride sustained release tablets Clinical effect
  • 相关文献

参考文献5

二级参考文献46

  • 1郭应禄,李宏军.前列腺炎的预防[J].中华男科学杂志,2002,8(3):157-161. 被引量:18
  • 2Schaeffer AJ,Knauss JS,Landis JR,et al.Leukocyte andbacterial counts do not correlate with severity of symptomsin men with chronic prostatitis:the National Institutes ofHealth Chronic Prostatitis Cohort Study[J].J Urol,2002,168(3):1048-1053.
  • 3Litwin MS,McNaughton-Collins M,Fowler FJ Jr,et al.TheNational Institutes of Health chronic prostatitis symptom index:development and validation of a new outcome measure.Chronic Prostatitis Collaborative Research Network[J].J Urol,1999,162(2):369-375.
  • 4鲍镇美.前列腺尿液返流与前列腺炎[J].中华泌尿外科杂志,1995,16:380.
  • 5Lee SW,Liong ML,Yuen KH,et al.Chronic prostatitis∕chronicpelvic pain syndrome:role of alpha blocker therapy[J].Urol Int,2007,78(2):97-105.
  • 6Nickel JC,Role of alphal -blockers in chronic prostatitissyndromes[J].BJU Int,2008,101(Suppl):11-16.
  • 7Mehik A,Alas P,Nickel JC,et al.Alfuzosin treatment forchronic prostatitis∕chronic pelvic pain syndrome: a prospective,randomized,double-blind,placebo-controlled,pilot study[J].Urology,2003,62(3):425-429.
  • 8Schaeffer AJ,Knauss JS,Landis JR, et al. Leukocyte and bacterial counts do not correlatr with severity of symp- toms in men with chronic prostatitis: the National Insti- tutes of Health Chromic Prostatitis Cohort Study [J]. J Urol,2002,168 ( 3 ): 1048-1053.
  • 9Krieger JN,Riley DE,Cheah PY, et al. Epidemiology of prostatitis: new evidence for a world-wide problem [J]. World J Urol, 2003, 21 (2) : 70-74.
  • 10Bartoletti R, Cai T, Mondaini N, et al. Prevalence ,inci- dence estimation,risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urolog- ical hospital outpatients in Italy: results of multicenter case-control observational study [J]. J Urol, 2007, 178 (6): 2411.

共引文献40

同被引文献18

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部